TELIOS PHARMACEUTICALS, INC.

ARGIDENE

pharmaceutical preparation for treatment of chronic and severe wounds;

MATRICOS

pharmaceutical preparation for wound healing and tissue regeneration;

MATRINEX

pharmaceutical preparation for wound healing and tissue regeneration;

MATRIX MEDICINE

house mark for a full line of pharmaceuticals in ointment, powder, tablet, solution, aerosol, polymer, particle, microshape, gel, and porous sheet form for the treatment of cancer, burns, skin ulcers, kidney disorders, tissue regeneration, organ and tissue wounds, fibrotic diseases, cardiovascular disorders, corneal wounds, and osteoporosis;MEDICINE;

OCUNEX

pharmaceutical preparation for the treatment of chronic and severe wounds;

PEPTIKOS

pharmaceutical preparation for wound healing and tissue regeneration;

PEPTINEX

pharmaceutical preparations for wound healing, tissue regeneration, and biocompatible coating of prosthetic implants;

PEPTITE

IN THE STATEMENT, COLUMN 1, LINES 5 AND 6, PEPTIDE-CONTAINING SHOULD BE DELETED. IN THE STATEMENT, COLUMN 2, LINE 3, 12-12-1989 SHOULD BE DELETED, AND 4-12-1989 SHOULD BE INSERTED. IN THE STATEMENT, COLUMN 2, LINE 4, 12-14-1989 SHOULD BE DELETED, AND 4-14-1989 SHOULD BE INSERTED.;cell-adhesive [ peptide-containing ] pharmaceutical preparations for use in coating medical devices prior to implantation;

PEPTITE-2000

cell-adhesive peptide containing pharmaceutical preparations for use in coating medical devices prior to implantation;

RGD PEPTIDES

SYNTHETIC PEPTIDES CONTAINING THE AMINO ACID SEQUENCE ARGININE-GLYCINE-ASPARTIC ACID FOR BIOCHEMICAL RESEARCH PURPOSES;PEPTIDES;

TELIO-DERM

pharmaceutical preparations for the treatment of chronic and severe wounds;

TELIOS PHARMACEUTICALS

HOUSE MARK FOR A FULL LINE OF BIOCHEMICALS FOR LABORATORY RESEARCH USE, NAMELY PROTEINS, ANTIBODIES AND PEPTIDES;PHARMACEUTICALS;